Hybrid Director, HTA, Value & Evidence, Specialty Care, Brepocitinib

Posted 2 months ago

Apply now

About the role

  • Director of HTA and Value Evidence for Brepocitinib at Pfizer, ensuring evidence generation and launch readiness during critical period.

Responsibilities

  • Review and the assessment of the Brepocitinib Clinical Study Report (CSR) to identify HEOR-relevant insights, evidence gaps and post-hoc analyses.
  • Prioritization of evidence gaps and coordination of ownership across Global HEOR, country affiliates, and alliance partner.
  • Contribution to the development and/or oversight of payer-relevant global launch evidence and narratives: Cost-effectiveness and budget impact models. Systematic Literature Reviews (Clinical, Economic, Humanistic, Epidemiology). Indirect treatment comparisons / network meta-analyses. Global Value Dossier. Patient-reported outcome and quality-of-life evidence generation. Real world evidence studies (e.g. treatment patterns, burden of illness/disease, epidemiology, real world effectiveness).
  • Lead or support HTA, Value & Evidence workstreams in close partnership with cross-functional global and local teams.
  • Ensure alignment of HTA, Value & Evidence activities with global strategy and launch timelines.
  • Develop real world evidence generation strategies and lead the execution of studies (e.g., treatment patterns, real world effectiveness, burden of illness studies, epidemiology studies, etc.) to generate evidence to support brand competitive differentiation and value proposition.
  • Lead the execution of clinically relevant and scientifically valid, cutting edge HV&E studies and projects (including non-interventional studies, registries, etc.) catered to diverse stakeholders (regulators, payers, patients, physicians and policy makers).
  • Lead the development of appropriate data dissemination plans and communicate in a timely manner.
  • Ensure all activities are conducted in compliance with Pfizer SOPs and governance requirements.

Requirements

  • BA/BS required with 8+ years of experience
  • Demonstrated expert understanding of fundamental health services research methods and tools including but not limited to: Health economics. Cost-effectiveness / budgetary impact modeling. Indirect treatment comparisons. Patient-reported outcomes / quality-of-life measures.
  • Experience managing multiple projects and working in a matrix environment.
  • Real world evidence studies.
  • Strong interpersonal skills and evidence of teamwork in a matrix environment.
  • Demonstrated ability to manage multiple projects with autonomy, involving complex processes, significant budget, competing deadlines, and rapidly shifting priorities in a compliant manner.
  • Proven ability to develop strong partnerships across multiple functions within a large group/company.
  • A track record with an “execution mindset” focused on getting things done quickly and simply.
  • Ability to understand, synthesize, and summarize complex topics.
  • Excellent oral and written English communication skills.
  • Nice-to-Have: MBA/MS with 7+ years of experience; OR PharmD or PhD in HEOR or a closely related field such as health economics, epidemiology, health services research, or another research-oriented public health discipline with 5+ years if experience.
  • Experience working with European HTA bodies such as NICE, CADTH, ICER and other reimbursement bodies is strongly preferred.
  • Experience supporting launch assets.
  • Knowledge and experience in I&I therapeutic areas is desirable.

Benefits

  • Eligible for Relocation Package – NO
  • Secondment 6-8 months

Job title

Director, HTA, Value & Evidence, Specialty Care, Brepocitinib

Job type

Experience level

Lead

Salary

Not specified

Degree requirement

Bachelor's Degree

Location requirements

Report this job

See something inaccurate? Let us know and we'll update the listing.

Report job